Sacha Mann joined Takeda Ventures, Inc. (TVI) in June 2021, as Senior Partner, and is based in Vancouver, British Columbia. She has a decade of experience in venture investing and complementary skills in company creation, management as biotech CEO, business development, and R&D. She has been an advisor and director for various life science companies, incubators/accelerators, and venture capital funds. Previously she was the CEO of Biosys, a venture-backed clinical stage microbiome company, and led several healthcare investments at Inventages. Prior to Inventages, Sacha was an early-stage investor focused on innovation and investment at Archangels and BDC Capital. Sacha holds a B.Sc. Honours in Chemistry from the University of British Columbia, a M.Sc. in Biotechnology from Johns Hopkins University, an MBA from Simon Fraser University, and she is a Kauffman Fellow.
Education, Personal, and Fellowship
She is a mentor in the health stream at the Creative Destruction Lab in Vancouver, and has participated on the board of non-profits. She was previously based in London where she founded the C100UK to support the growth of Canadian entrepreneurs as they scale their businesses into Europe.
Sacha Mann is a member of Kauffman Fellows Class 12 and served her fellowship under mentor John Waddell at Archangel Informal Investment In Edinburgh, Scotland.